Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Public ClinicalTrials.gov record NCT03110562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Study identification
- NCT ID
- NCT03110562
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Karyopharm Therapeutics Inc
- Industry
- Enrollment
- 402 participants
Conditions and interventions
Conditions
Interventions
- Bortezomib Drug
- Dexamethasone Drug
- Selinexor Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2017
- Primary completion
- Feb 17, 2020
- Completion
- May 11, 2022
- Last update posted
- Aug 20, 2024
2017 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boca Raton Clinical Research (BRCR) Medical Center | Plantation | Florida | 33324 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Kaiser Permanente Hawaii | Honolulu | Hawaii | 96817 | — |
| McFarland Clinic | Ames | Iowa | 50010 | — |
| Stormont Vail Health Care (Cotton O'Neil Cancer Center ) | Topeka | Kansas | 66606 | — |
| Commonwealth Hematology | Danville | Kentucky | 40422 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Central Care Cancer Center | Bolivar | Missouri | 65613 | — |
| The Valley Hospital Luckow Pavilion | Paramus | New Jersey | 07652 | — |
| Mount Sinai | New York | New York | 10029 | — |
| The Cancer Institute at St. Francis Hospital | Roslyn | New York | 11576 | — |
| Novant-Forsyth Memorial Hospital | Winston-Salem | North Carolina | 27103 | — |
| University of Cincinnati Health | Cincinnati | Ohio | 45267 | — |
| Southwest Cancer Center of Oklahoma | Lawton | Oklahoma | 73505 | — |
| Kaiser Permanente Northwest OR | Portland | Oregon | 97210 | — |
| SCOR AnMed Health Cancer Center | Anderson | South Carolina | 29621 | — |
| Prairie Lakes Healthcare | Watertown | South Dakota | 57201 | — |
| Baylor Sammons Cancer Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern | Dallas | Texas | 75390 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03110562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2024 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03110562 live on ClinicalTrials.gov.